Living in a modern age where everything is becoming man-synthesized and chemically composed, has many advantages as well as disadvantages. An unfortunate disadvantage is the spread of new lethal diseases such as AIDS, SARCS and even new breads of cancer developing from body intoxications. Stomach cancer is a lethal and life threatening disease with a lot of symptoms, including death, but no effective solutions till our time.

Stomach cancer is the 4th most commonly type of cancer worldwide with a high death rate (around 700,000 a year). The disease is usually associated with salty diet, low intake of fruits and vegetable and smoking. Other causes can be Helicobacter pylori infection, intestinal metaplasia, and gastritis. Stomach cancer is sometimes asymptomatic causing its poor Prognosis for Stomach Cancer since it usually metastasize to other body parts. Several symptoms have been recorded such as loss of appetite, indigestion, abdominal pain, nauseam diarrhea, weight loss, weakness, bleeding and Dysphagia.

For a proper Prognosis for Stomach Cancer of Stomach cancer, several laboratory studies are made accompanied with a full study of the patient’s medical history and a full physical exam. Several tests are carried out on the patient such as Gastroscopic exam, involves the insertion of fiber optic camera for further visualizations of the infected area, Cytology, Staging and Computed tomography. Furthermore, staging the disease will give important information to help determine the extent of infection. This information will be used for further prognosis that is affected by many factors:
- The location and type of the cancer
- The stage or extent of the disease
- The grade of the disease (how abnormal do the cells look and how fast is the cancer growth and spread)
- The patient’s age, general health, location, and response to the treatment.
Stomach cancer can be treated with surgery, which is the most common treatment and involves high risks, chemotherapy, radiation therapy and multimodality therapy. Survival rates due to treatment are about 14% with a growing potential of another future risk.
The rates of survival depend on the patient’s condition and stage of the disease. An overall survival period is five years depending on many factors. The five-year relative survival rates are about 20% with higher rates for women than that of men.
After weighing all the factors that could affect the patient’s disease and treatment, a priminary prognosis is predicted by the doctor. However, this Prognosis for Stomach Cancer is considered a prediction as the doctors are unable to be absolutely certain of any outcome of the patient’s disease.

Molecular breast imaging (MBI) detected three times as many breast cancers in women who have dense breasts and who are at a higher risk of developing the disease. The MBI is able to locate differences between normal tissue vs. cancer tissue.

With the new screening Doctors will be able to dectect and treat cancer in women fast and more effectively, and the faster that cancer is detected the better rate of survival.  It is breakthrough’s in cancer screening that leads me to believe that one day we will find a cure for breast cancer.

But for now we can increase there chances of beating cancer by a simple MBI sceening.